SALURON Drug Patent Profile
✉ Email this page to a colleague
When do Saluron patents expire, and what generic alternatives are available?
Saluron is a drug marketed by Shire Llc and is included in one NDA.
The generic ingredient in SALURON is hydroflumethiazide. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SALURON?
- What are the global sales for SALURON?
- What is Average Wholesale Price for SALURON?
Summary for SALURON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Patent Applications: | 4,793 |
| DailyMed Link: | SALURON at DailyMed |
US Patents and Regulatory Information for SALURON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shire Llc | SALURON | hydroflumethiazide | TABLET;ORAL | 011949-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
